Volume 29, Number 9—September 2023
Dispatch
Home-Based Testing and COVID-19 Isolation Recommendations, United States
Figure

Figure. Crude and adjusted odds ratios and 95% CIs comparing COVID-19 isolation, isolation duration, and self-notification of contacts by SARS-CoV-2 test administration type, United States, January 2021–March 2022. Multivariable models included population-weighted individual survey responses controlled for age, sex, race/ethnicity, US state of residence, household size, household income, and urbanicity (i.e., urban, suburban, or rural). Isolation and notification likelihood of home-based testing is in comparison to provider-administered tests. Vertical dashed line indicates the null or no statistical association. OR, odds ratio.
Page created: August 07, 2023
Page updated: August 20, 2023
Page reviewed: August 20, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.